187 related articles for article (PubMed ID: 31243601)
21. Preparation and characterization of colon-targeted pH/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers.
Turanlı Y; Acartürk F
Eur J Pharm Sci; 2022 Apr; 171():106122. PubMed ID: 35007712
[TBL] [Abstract][Full Text] [Related]
22. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
[TBL] [Abstract][Full Text] [Related]
23. Swellable polymeric particles for the local delivery of budesonide in oral mucositis.
Campos JC; Ferreira DC; Lima S; Reis S; Costa PJ
Int J Pharm; 2019 Jul; 566():126-140. PubMed ID: 31129342
[TBL] [Abstract][Full Text] [Related]
24. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
25. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
[TBL] [Abstract][Full Text] [Related]
26. Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation.
Varshosaz J; Minaiyan M; Khaleghi N
J Microencapsul; 2015; 32(3):211-23. PubMed ID: 25561026
[TBL] [Abstract][Full Text] [Related]
27. Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
Avachat AM; Shinde AS
Drug Dev Ind Pharm; 2016 Jan; 42(1):80-90. PubMed ID: 25923416
[TBL] [Abstract][Full Text] [Related]
28. Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.
Soltani F; Kamali H; Akhgari A; Ghasemzadeh Rahbardar M; Afrasiabi Garekani H; Nokhodchi A; Sadeghi F
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678698
[TBL] [Abstract][Full Text] [Related]
29. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.
Frank LA; Sandri G; D'Autilia F; Contri RV; Bonferoni MC; Caramella C; Frank AG; Pohlmann AR; Guterres SS
Int J Nanomedicine; 2014; 9():3151-61. PubMed ID: 25061292
[TBL] [Abstract][Full Text] [Related]
30. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E
Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968
[TBL] [Abstract][Full Text] [Related]
31. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
[TBL] [Abstract][Full Text] [Related]
32. Preparation, in vitro and in vivo evaluation of budesonide loaded core/shell nanofibers as oral colonic drug delivery system.
Xu Q; Zhang N; Qin W; Liu J; Jia Z; Liu H
J Nanosci Nanotechnol; 2013 Jan; 13(1):149-56. PubMed ID: 23646710
[TBL] [Abstract][Full Text] [Related]
33. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
34. Fabrication, Physico-Chemical, and Pharmaceutical Characterization of Budesonide-Loaded Electrospun Fibers for Drug Targeting to the Colon.
Bruni G; Maggi L; Tammaro L; Canobbio A; Di Lorenzo R; D'aniello S; Domenighini C; Berbenni V; Milanese C; Marini A
J Pharm Sci; 2015 Nov; 104(11):3798-3803. PubMed ID: 26183222
[TBL] [Abstract][Full Text] [Related]
35. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
Simonoska Crcarevska M; Glavas Dodov M; Goracinova K
Eur J Pharm Biopharm; 2008 Mar; 68(3):565-78. PubMed ID: 17651952
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
[TBL] [Abstract][Full Text] [Related]
37. Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat.
Varshosaz J; Ahmadi F; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
J Microencapsul; 2011; 28(1):62-73. PubMed ID: 21171817
[TBL] [Abstract][Full Text] [Related]
38. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
40. Colon-specific delivery of budesonide with azopolymer-coated pellets: therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Tozaki H; Fujita T; Komoike J; Kim SI; Terashima H; Muranishi S; Okabe S; Yamamoto A
J Pharm Pharmacol; 1999 Mar; 51(3):257-61. PubMed ID: 10344625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
